Is there a new drug beyond floxuridine for intra-arterial hepatic chemotherapy in liver metastases from colorectal cancer? [1]

Journal of Clinical Oncology

Volumn 23, Issue 9, 2005, Pages 2105-

  Fiorentini, G ^a   Rossi, S ^a   Bernardeschi, P ^a   Cantore, M ^a   Guadagni, S ^a  

^a SAN GIUSEPPE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; DEXAMETHASONE; FLOXURIDINE; FLUOROURACIL; IRINOTECAN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE;

ADJUVANT THERAPY; CLINICAL TRIAL; COLORECTAL CANCER; DISEASE COURSE; DRUG CLEARANCE; DRUG EXCRETION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; LETTER; LIVER METASTASIS; PRIORITY JOURNAL; COLORECTAL TUMOR; INTRAARTERIAL DRUG ADMINISTRATION; LIVER TUMOR; METASTASIS; NOTE; PATHOLOGY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; DEXAMETHASONE; FLOXURIDINE; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS;

EID: 15744382206     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.99.297     Document Type: Letter

References (9)

1. Kemeny N, Jarnagin W, Gonen M, et al: Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. J Clin Oncol 21:3303-3309, 2003
2. Gorlick R, Metzger R, Danenberg KD, et al: Higher levels of tymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma. J Clin Oncol 16:1465-1469, 1998
3. Davies MM, Johnston PG, Kaur S, et al: Colorectal liver metastasis thymidylate synthase staining corrlates with response to hepatic arterial floxuridine. Clin Cancer Res 5:325-328, 1999
4. Berg RW, Ferguso PJ, DeMoor JM, et al: The means to an end of tumor cell resistence to chemotherapeutic drugs targeting thymidylate sunthase: Shoot the messenger. Curr Drug Targets 3:297-309, 2002
5. Gupta E, Lestingi TM, Mick R, et al: Metabolic fate of irinotecan in humans: Correlation of glucoronidation with diarrea. Cancer Res 54:3723-3725, 1994
6. Rivory LP, Robert J: Identification and kinetics of a b-glucuronide of SN-38 in human plasma after administration of the campttothecin derivative irinotecan (CPT-11). Cancer Chemother Pharmacol 36:176-179, 1995
7. Guichard S, Hennebelle I, Chevreau, et al: CPT-11 converting carboxilesterase in tumor and in normal colon and liver tissues. Br J Cancer 80:364-370, 1999
8. Fiorentini G, Ricci Lucchi S, Giovanis P, et al: Irinotecan hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: Results of a phase I clinical study. Tumori 87:388-390, 2001
9. Fiorentini G, Rossi S, Dentico P, et al: Irinotecan hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: A phase II clinical study. Tumori 89:382-384, 2003